197 results on '"Stollenwerk, Björn"'
Search Results
2. Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial
3. Cost-effectiveness of romosozumab for the treatment of postmenopausal women at very high risk of fracture in Canada
4. Economic modeling of risk-adapted screen-and-treat strategies in women at high risk for breast or ovarian cancer
5. Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan
6. Cost-effectiveness of different strategies to prevent breast and ovarian cancer in German women with a BRCA 1 or 2 mutation
7. A Decision-Analytic Model to Assess the Cost-Effectiveness of Etelcalcetide vs. Cinacalcet
8. Depression-related treatment and costs in Germany: Do they change with comorbidity? A claims data analysis
9. Cost-of-illness studies based on massive data: a prevalence-based, top-down regression approach
10. The excess health care costs of KardioPro, an integrated care program for coronary heart disease prevention
11. Cost-effectiveness of a multifactorial fracture prevention program for elderly people admitted to nursing homes
12. Accounting for increased non-target-disease-specific mortality in decision-analytic screening models for economic evaluation
13. Transparency vs. closed-door policy: Do process characteristics have an impact on the outcomes of coverage decisions? A statistical analysis
14. Cost-Effectiveness of an Individualized First-Line Treatment Strategy Offering Erlotinib Based on EGFR Mutation Testing in Advanced Lung Adenocarcinoma Patients in Germany
15. Validity, reliability and responsiveness of the EQ-5D in German stroke patients undergoing rehabilitation
16. Cost Effectiveness of Rivaroxaban for Stroke Prevention in German Patients with Atrial Fibrillation
17. A Systematic Review of the Quality of Economic Models Comparing Thrombosis Inhibitors in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
18. C-Reactive Protein Levels and Post-ICU Mortality in Nonsurgical Intensive Care Patients
19. Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12Cmutation: a randomised, open-label, phase 3 trial
20. Prognostische Wertigkeit und klinische Effektivität des hochsensitiven C-reaktiven Proteins als Marker in der Primärprävention der koronaren Herzkrankheit
21. Have statins met our expectations? A comparison of expected health gains from statins with epidemiological trends in Austria
22. Cost Effectiveness of External Hip Protectors in the Hospital Setting: A Modeling Study
23. Serum antibodies against Saccharomyces cerevisiae: a new prognostic indicator in metastatic renal-cell carcinoma
24. Preliminary analysis of short term financial implications of a prevention bonus program: First results from the German statutory health insurance
25. Bürgerversicherung und Gesundheit
26. Evaluation of multi-dose repackaging for individual patients in long-term care institutions: savings from the perspective of statutory health insurance in Germany
27. A multi-perspective cost-effectiveness analysis comparing rivaroxaban with enoxaparin sodium for thromboprophylaxis after total hip and knee replacement in the German healthcare setting
28. Costs and effects of intra-operative fluorescence molecular imaging – A model-based, early assessment
29. Reporting health care decision models: a prospective reliability study of a multidimensional evaluation framework.
30. Exploring the potential value of improved care for secondary hyperparathyroidism with a novel calcimimetic therapy
31. Cost-effectiveness of different strategies to prevent breast and ovarian cancer in German women with a BRCA 1 or 2 mutation
32. Reporting health care decision models: a prospective reliability study of a multidimensional evaluation framework
33. Economic evaluation of genetic screening for Lynch syndrome in Germany
34. The cost-effectiveness of UGT1A1 genotyping before colorectal cancer treatment with irinotecan from the perspective of the German statutory health insurance
35. Effects of a 3-Year Nurse-Based Case Management in Aged Patients with Acute Myocardial Infarction on Rehospitalisation, Mortality, Risk Factors, Physical Functioning and Mental Health. A Secondary Analysis of the Randomized Controlled KORINNA Study
36. Cost-of-illness studies based on massive data: a prevalence-based, top-down regression approach
37. Prognostic value, clinical effectiveness, and cost-effectiveness of high-sensitivity C-reactive protein as a marker for major cardiac events in asymptomatic individuals : A health technology assessment report
38. The Effectiveness of the Cardiovascular Disease Prevention Programme ‘KardioPro’ Initiated by a German Sickness Fund: A Time-to-Event Analysis of Routine Data
39. Cost Effectiveness of Rivaroxaban for Stroke Prevention in German Patients with Atrial Fibrillation
40. Prognostic value, clinical effectiveness and cost-effectiveness of high sensitivity C-reactive protein as a marker in primary prevention of major cardiac events
41. Stellenwert des hochsensitiven C-reaktiven Proteins (hs-CRP) als Marker für Herzinfarktgefährdung
42. Einbeziehung der privaten Krankenvollversicherung in den Risikostrukturausgleich der gesetzlichen Krankenversicherung in Deutschland: Abschätzung der quantitativen Auswirkungen
43. Die Finanzierung des Gesundheitssystems auf dem Weg einer Bürgerversicherung. Ethische und ökonomische Grundüberlegungen
44. Auswirkungen der ersten und zweiten Stufe der Tabaksteuererhöhung
45. Should health insurers target prevention of cardiovascular disease?: a cost-effectiveness analysis of an individualised programme in Germany based on routine data
46. Cost-effectiveness of a multifactorial fracture prevention program for elderly people admitted to nursing homes
47. The cost-utility of open prostatectomy compared with active surveillance in early localised prostate cancer
48. Communicating the Parameter Uncertainty in the IQWiG Efficiency Frontier to Decision‐Makers
49. Effects of a nurse-based case management compared to usual care among aged patients with myocardial infarction: results from the randomized controlled KORINNA study
50. Link between Process and Appraisal in Coverage Decisions
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.